重症监护室创伤性脑损伤患者的精神药物使用:多中心观察性研究
本研究基于芬兰重症监护联盟数据库,回顾性纳入2003-2013年四所大学医院ICU收治的成年TBI患者,分析伤后精神药物使用情况及与晚期死亡率的关系。结果显示17%的1年存活者成为新精神药物使用者,以抗抑郁药为主;GCS评分越高使用几率越低,弥漫性损伤伴中线移位则几率更高;新使用精神药物与晚期死亡率升高相关。
要点
- TBI存活者中17%新使用精神药物,最常见为抗抑郁药。
- GCS评分越高,新使用精神药物的几率越低。
- 新使用精神药物与晚期全因死亡率升高相关。
核心结论
- TBI存活者精神药物使用常见,严重程度越高使用几率越大,新使用与晚期死亡率升高相关。
研究设计与样本
- 回顾性多中心观察性研究,使用芬兰重症监护联盟数据库,纳入2003-2013年四所大学医院ICU收治的成年TBI患者,随访至2016年底。
主要发现
- 3061例患者中2305例(75%)在1年时存活,其中400例(17%)成为新精神药物使用者。
- 最常见药物类型为抗抑郁药(61%)、抗精神病药(35%)和抗焦虑药(26%)。
- GCS评分较高与新使用精神药物几率降低相关(OR 0.93,95% CI 0.90-0.96)。
- 弥漫性损伤伴中线移位与新使用精神药物几率升高相关(OR 3.4,95% CI 1.3-9.0)。
- 新使用精神药物与晚期全因死亡率升高相关(OR 1.19,95% CI 1.19-2.17,中位随访6.4年)。
临床怎么用
- 对TBI存活者应早期识别潜在精神后遗症并进行精神科评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psychiatric sequelae after traumatic brain injury (TBI) are common and may impede recovery. We aimed to assess the occurrence and risk factors of post-injury psychotropic medication use in intensive care unit (ICU)-treated patients with TBI and its association with late mortality. METHODS: We conducted a retrospective multi-centre observational study using the Finnish Intensive Care Consortium database. We included adult TBI patients admitted in four university hospital ICUs during 2003-2013 that were alive at 1 year after injury. Patients were followed-up until end of 2016. We obtained data regarding psychotropic medication use through the national drug reimbursement database. We used multivariable logistic regression models to assess the association between TBI severity, treatment-related variables and the odds of psychotropic medication use and its association with late all-cause mortality (more than 1 year after TBI). RESULTS: Of 3061 patients, 2305 (75%) were alive at 1 year. Of these, 400 (17%) became new psychotropic medication users. The most common medication types were antidepressants (61%), antipsychotics (35%) and anxiolytics (26%). A higher Glasgow Coma Scale (GCS) score was associated with lower odds (OR 0.93, 95% CI 0.90-0.96) and a diffuse injury with midline shift was associated with higher odds (OR 3.4, 95% CI 1.3-9.0) of new psychotropic medication use. After adjusting for injury severity, new psychotropic medication use was associated with increased odds of late mortality (OR 1.19, 95% CI 1.19-2.17, median follow-up time 6.4 years). CONCLUSIONS: Psychotropic medication use is common in TBI survivors. Higher TBI severity is associated with increased odds of psychotropic medication use. New use of psychotropic medications after TBI was associated with increased odds of late mortality. Our results highlight the need for early identification of potential psychiatric sequelae and psychiatric evaluation in TBI survivors.
引用
- Vehviläinen J, Skrifvars MB, Reinikainen M, et al. Psychotropic medication use among patients with a traumatic brain injury treated in the intensive care unit: a multi-centre observational study. Acta Neurochir (Wien). 2021. PMID: 34379205. doi:10.1007/s00701-021-04956-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。